Kaleido Biosciences's market cap is currently $43.00. The company's EPS TTM is $; its P/E ratio is ―; Kaleido Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 0.00	$ 1.10M	$ 975.00K	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ -1.25M	$ 919.03K	$ -1.32M	$ 0.00
Operating Income	$ 0.00	$ -87.67M	$ -78.87M	$ -86.66M	$ -60.68M
EBITDA	$ 0.00	$ -85.09M	$ -77.00M	$ -86.66M	$ -59.03M
Net Income	$ 0.00	$ -93.27M	$ -79.80M	$ -85.01M	$ -61.74M
Balance Sheet
Cash & Short-Term Investments	$ 0.00	$ 38.47M	$ 46.22M	$ 71.24M	$ 76.09M
Total Assets	$ 0.00	$ 50.14M	$ 59.34M	$ 82.31M	$ 85.33M
Total Debt	$ 0.00	$ 21.69M	$ 21.01M	$ 20.46M	$ 14.92M
Net Debt	$ 0.00	$ -16.78M	$ -25.21M	$ -50.78M	$ -61.16M
Total Liabilities	$ 0.00	$ 39.53M	$ 38.85M	$ 33.42M	$ 27.13M
Stockholders' Equity	$ 0.00	$ 10.61M	$ 20.50M	$ 48.88M	$ 58.20M
Cash Flow
Free Cash Flow	$ 0.00	$ -78.22M	$ -65.54M	$ -79.38M	$ -49.32M
Operating Cash Flow	$ 0.00	$ -77.09M	$ -61.52M	$ -75.80M	$ -46.32M
Investing Cash Flow	$ 0.00	$ -691.00K	$ -4.02M	$ -3.59M	$ -3.00M
Financing Cash Flow	$ 0.00	$ 70.04K	$ 40.40M	$ 74.64M	$ 98.91M

Currency in USD

Kaleido Biosciences Earnings and Revenue History

Income Statement >

Kaleido Biosciences Debt to Assets

Balance Sheet >

Kaleido Biosciences Cash Flow

Cash Flow >

Kaleido Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing